About Us
The RenalPro System stands out for its simple, elegant technology: ideal for kidney preservation and AKI prevention.
Our mission is to help improve morbidity and mortality rates, preserve quality of life, and reduce healthcare costs with our proprietary, IP-rich innovations currently protected by 22 patents and patent pending applications.
Management Team
Decade of experience guiding strategic product and business development. Managing Partner at Imagine Bio, a strategic consultancy that supported innovation strategy at clients such as JNJ and Boehringer Ingelheim. Former CEO at NeuroQuest. Studied finance and biochemistry at Miami Univ. of Ohio.
Ilya Budik
CEO
Ethan Benovitz is a seasoned investor with more than 25 years of experience investing in the healthcare and technology sectors. He began his career as a corporate attorney after earning his JD from Harvard Law School. Ethan’s expertise in strategy, corporate finance and governance make him a trusted advisor to a variety of corporations and executives.
Ethan Benovitz, JD
Chairman
18 years of experience managing clinical and regulatory affairs at emerging medtech companies, including dozens of clinical trials as well as FDA, CE, and Japanese approvals at Nucleix, Oridian (acq. by Medtronic), and Brainsway (NASDAQ: BWAY).
Shmulik Adler
SVP Clinical & Regulatory AffairsLaura Dern
President
Cardiothoracic surgeon with 25+ years of clinical experience in UK and UAE. Involved in clinical validation of three emerging medical technologies including RenalGuard’s UK validation study in CSA-AKI. Author of 137 peer-reviewed publications.
Heyman Luckraz, FRCS, MD
SVP Medical Affairs
Former Chief Medical Officer at Covidien, GE Healthcare, and Cheetah Medical (acq. by Baxter for $238 million). Practicing anesthesiologist at Harvard’s Mass General Hospital.
William “Pepper” Denman, MD
Sr. Medical & Industry Advisor
Partner at Hogan Lovells. Extensively recognized as leading regulatory advisor with over 25 years of experience guiding dozens of innovative devices through successful FDA approvals. BS mechanical engineering at MIT, JD Georgetown.
Janice Hogan, JD
Sr. Regulatory Advisor
40+ years of experience in medical device sales in US, EMEA, and APAC regions. Led Acist sales launch through growth and post-acquisition to Bracco. Track record of international expansion, distribution management, and channel marketing.
Robin Luper,
SVP Sales, International
20+ years experience managing finance in tech and biotech companies including taking Regenocell Labs public on Nasdaq, acquisition of Magnifire by F5 Networks, and company financings totaling over $100 million. Formerly senior accountant at KPMG. BA Accounting from York Univ.
Tzvi Stern,CPA
CFO
Manages business development and operations projects. Previously served as a Sr. Analyst of healthcare innovation at Imagine Bio. He worked for Healthcare Solutions. Studied Biology at Northland College in Wisconsin.
Avi Wise
Dir. of Business Operations
With over 11 years of experience in the medical device industry, Yael has held key roles as a Clinical Research Associate (CRA), Senior CRA, and Project Manager. As a vital member of the clinical department, she has led and managed all aspects of clinical studies across Israel, Europe, and the United States. She holds a Bachelor’s degree in Occupational Therapy from Hebrew University and an MBA in Business Management.
Yael Sendak
Senior CRA
A results-driven Clinical Operations professional with extensive experience leading multinational clinical trials from Phase I to Phase IIIb, culminating in the successful approval of an FDA Biologics License Application (BLA). Proven expertise in Clinical Quality Assurance, SOP development, and Inspection Readiness, ensuring regulatory compliance and operational excellence.
Uri Goshen
Senior Clinical Project Manager
Kristin is a highly organized and detail-oriented Office Manager with extensive experience in the medical device industry. She plays a key role in ensuring smooth daily operations by overseeing office management, shipping logistics, and accounts payable
Kristin Oaks
Office ManagerScientific Advisory Board
Leading KOL in CSA-AKI and principal investigator for numerous important trials. Member of Enhanced Recovery After Surgery (ERAS) society.
Prof. Alex Zarbock, MD
Anesthesiologist, University Hospital Münster
Prof. of Nephrology at Univ. of Vermont. Leading KOL in field of AKI and principal investigator for numerous important trials. Member of the NIH consortium for AKI biomarkers.
Richard Solomon, MD
Nephrologist, University of Vermont
Assc. Professor of Medicine at Harvard Medical School. Director of Clinical & Translational Research in AKI at Brigham & Women’s Hospital. Recognized KOL with extensive clinical publications on CSA-AKI related research.
David Leaf, MD
Nephrologist, Harvard Medical School
Cardiothoracic Surgeon and Medical Director of Heart, Vascular and Critical Care Unit at Baystate Medical Center. Head of ERAS (Enhanced Recovery After Surgery) Society.
Dan Engelman, MD
Cardiothoracic Surgeon, Head of ERAS Society
Chair, Department of Surgery at Baylor College of Medicine and Texas Heart Institute. KOL with extensive clinical research and publications in Cardiac Surgery and CSA-AKI.
Todd Rosengart, MD, FACS
Cardiothoracic Surgeon, Baylor College of MedicineOur Investors
